Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Nashville, Tennessee 37232


Purpose:

The purpose of this study is to look at certain areas of the brain that are related to addictive behaviors, such as overeating. These areas are called 'dopamine type 2 receptors' (DRD2) and other studies have shown that obese people have less of these. We propose that low DRD2 availability seen in morbidly obese subjects will change with weight loss associated with bariatric surgery.


Criteria:

Inclusion Criteria: - Ages 18-60 years - BMI equal to or greater than 40, or equal to or greater than 35 if there are 2 or more co-morbidities - Weight less than 350 pounds Exclusion Criteria: - History of substance abuse,including but not limited to alcohol, cocaine, marijuana, heroin, nicotine - History of psychiatric disorders - Use of any antidepressants or psychotropics in the past 12 months - Diabetes Mellitis - Positive pregnancy test - Any condition felt by the PI or co-investigators to interfere with the individual's ability to complete the study - Subjects on medications for the last 3 months, such as sibutramine, which could affect the quality of the study, as determined by the PI - Inability to travel to Nashville, TN four times


NCT ID:

NCT00801827


Primary Contact:

Principal Investigator
Julia P Dunn, MD
Vanderbilt University


Backup Contact:

N/A


Location Contact:

Nashville, Tennessee 37232
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.